Coronary disease & ACSSecondary analysis

Optical coherence tomography-guided percutaneous coronary intervention in multivessel coronary disease with complex lesions

HeartPublished

  • post hoc subgroup analysis of the OCCUPI trial

Authors' conclusion

In patients with MVD and complex lesions, OCT-guided PCI was associated with a lower risk of 1-year MACE than angiography-guided PCI particularly when stent optimisation on OCT was achieved.

Study context

Population
Patients with multivessel disease (MVD) (diameter stenosis ≥50% in ≥2 major epicardial coronary arteries) with at least one complex lesion undergoing percutaneous coronary intervention (PCI)patients with MVD among the as-treated population in the OCCUPI trial (n=1604), 575 had single-vessel disease
Participants
985 patients
Comparison
Optical coherence tomography (OCT)-guided PCI vs angiography-guided PCI in patients with MVD
  • OCT-guided PCIn = 515
  • angiography-guided PCIn = 470
Primary endpoint
MACE, a composite of cardiac death, myocardial infarction, stent thrombosis or ischaemia-driven target-vessel revascularisation
Follow-up
1 year

Primary result

As reported in the abstract

Hazard ratio

0.51

95% CI 0.31–0.85

P = 0.008

By group

OCT-guided PCI vs angiography-guided PCI
HR 0.51 (95% CI 0.31–0.85); P = 0.008

Further findings

Achievement of prespecified OCCUPI optimisation criteria among OCT-guided patients

achieved optimisation criteria
355 (70.2%)
did not achieve optimisation criteria
151 (29.8%)

Major adverse cardiac event (MACE) by stent optimisation (optimised vs not optimised)

stent optimisation vs no optimisation MACE rates
3.1% vs 8.6%; p=0.011
  • consistent benefits across MVD and single-vessel disease (p for interaction=0.521)

Original publication

Optical coherence tomography-guided percutaneous coronary intervention in multivessel coronary disease with complex lesions. Heart. Published 26 August 2026. doi:10.1136/heartjnl-2026-328499

Summarised from the published abstract; every number is checked against it